0001886259-22-000004.txt : 20220818 0001886259-22-000004.hdr.sgml : 20220818 20220818180408 ACCESSION NUMBER: 0001886259-22-000004 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220816 FILED AS OF DATE: 20220818 DATE AS OF CHANGE: 20220818 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Benmoussa Kevin CENTRAL INDEX KEY: 0001886259 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40950 FILM NUMBER: 221178361 MAIL ADDRESS: STREET 1: C/O THE VITA COCO COMPANY, INC. STREET 2: 250 PARK AVENUE SOUTH, SEVENTH FLOOR CITY: NEW YORK STATE: NY ZIP: 10003 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vita Coco Company, Inc. CENTRAL INDEX KEY: 0001482981 STANDARD INDUSTRIAL CLASSIFICATION: BEVERAGES [2080] IRS NUMBER: 113713156 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 39 WEST 14TH STREET, SUITE 404 CITY: NEW YORK STATE: NY ZIP: 10011 BUSINESS PHONE: 212-206-0763 MAIL ADDRESS: STREET 1: 39 WEST 14TH STREET, SUITE 404 CITY: NEW YORK STATE: NY ZIP: 10011 FORMER COMPANY: FORMER CONFORMED NAME: All Market Inc. DATE OF NAME CHANGE: 20210824 FORMER COMPANY: FORMER CONFORMED NAME: All Market, Inc. DATE OF NAME CHANGE: 20210824 FORMER COMPANY: FORMER CONFORMED NAME: Vita Coco Company, Inc. DATE OF NAME CHANGE: 20210823 4 1 wf-form4_166086023338835.xml FORM 4 X0306 4 2022-08-16 0 0001482981 Vita Coco Company, Inc. COCO 0001886259 Benmoussa Kevin 250 PARK AVENUE SOUTH 7TH FLOOR NEW YORK NY 10003 0 1 0 0 Global Chief Financial Officer Common Stock 2022-08-16 4 M 0 24381 10.178 A 34531 D Common Stock 2022-08-16 4 S 0 9381 16.01 D 25150 D Common Stock 2022-08-16 4 S 0 15000 15.11 D 10150 D Common Stock 2022-08-16 4 M 0 1894 10.178 A 12044 D Common Stock 2022-08-17 4 S 0 1894 16 D 10150 D Stock Option (Right to Buy) 10.178 2022-08-16 4 M 0 24381 0 D 2029-12-16 Common Stock 24381.0 59369 D Stock Option (Right to Buy) 10.178 2022-08-17 4 M 0 1894 0 D 2029-12-16 Common Stock 1894.0 57475 D Stock Option (Right to Buy) 10.178 2030-02-10 Common Stock 56875.0 56875 D Stock Option (Right to Buy) 10.178 2031-01-11 Common Stock 27300.0 27300 D Stock Option (Right to Buy) 15.0 2031-10-20 Common Stock 49751.0 49751 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $16.00 to $16.03, inclusive. The Reporting Person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.28, inclusive. The Reporting Person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.00 to $16.02, inclusive. The Reporting Person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Includes (i) 10,000 unvested RSUs that vest in four annual installments starting November 27, 2022 provided that the Reporting Person remains in continuous service on each vesting date and (ii) 150 shares of common stock purchased directly from the issuer's underwriters in a Reserved Share Program. The stock option is fully vested and currently exercisable. The stock option vests on February 10, 2024. The stock option vests in two equal biennial installments beginning on January 11, 2023. The stock option vests in four equal annual installments beginning on November 27, 2022. /s/ Yolanda Goettsch, Attorney-in-fact 2022-08-18